Many findings indicated that the beginning and progression of neurodegenerative human diseases such as Alzheimer's disease (AD) and multiple sclerosis (MS) are affected by the dysregulation of PAD2 activity. This evidence concerns the gene PADI2 and multiple sclerosis.